The Metabolic Effects of Hawthorn Vinegar in Patients with High Cardiovascular Risk Group

Zehra Kadas¹, Gulsun Akdemir Evrendilek^1, and Gulumser Heper²

¹Abant Izzet Baysal University Faculty of Engineering and Architecture Department of Food Engineering Golkoy Campus, Bolu Turkey

²Ozel Kudret International Hospital GMK Boulevard No: 81 Maltepe Ankara Turkey

Cite this paper:
Zehra Kadas, Gulsun Akdemir Evrendilek and Gulumser Heper. The Metabolic Effects of Hawthorn Vinegar in Patients with High Cardiovascular Risk Group. Journal of Food and Nutrition Research. 2014; 2(9):539-545. doi: 10.12691/jfnr-2-9-2

Abstract

Hawthorn (Crataegus oxycantha) vinegar produced traditionally only in Bolu (Turkey) in small amount is believed to cure some diseases such as cold, flu and cardiovascular diseases by local people. However, very limited amount of information is available regarding the health effect of hawthorn vinegar. In order to investigate the metabolic effects of hawthorn vinegar 37 patients who were diabetic, hypertensive, overweight and taking related medications with high cardiovascular risk group were selected and without changing their diet habits and exercise program, vinegar consumption was added to each meal during four-week. There was a significant change on the weight loss, BMI change, blood pressure decrease, glucose, cholesterol, trigliseride, LDL, HDL and cholesterol/HDL after consumption of Hawthorn vinegar (p≤0.05). Total phenolic substance concentration (mg/mL) and total monomeric anthocyanin content (mg/L) and total antioxidant capacity (%) of the Hawthorn vinegar were measured as 0.51, 0.25 and 77, respectively. This study demonstrates that Hawthorn vinegar has positive metabolic effects on the patients with high cardiovascular risk factors.

Keywords:
hawthorn vinegar metabolism weight loss preventive medicine

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	McGovern, P. E., Zhang, J., Tang, J., Zhang Z, Hall, G. R., Moreau, R. A., Nunez, A., Butrym, E. D., Richards, M. P., Wang, C. S., Cheng, G., Zhao, Z., and Wang, C. “Fermented beverages of pre-and proto-historic China”. Proc. Nat. Aca. Sci, 101, 17593-8. 2004.
[2]	Zhang, Z. S., Ho, W. K. K., Huang, Y., and Chen, Z. Y. “Hypocholesterolemic activity of hawthorn fruit is mediated by regulation of cholesterol-7alpha-hydroxylase and acyl CoA: cholesterol acyltransferase.” Food Res. Int. 35, 885-91. 2002.
[3]	Zhang, Z. S., Ho, W. K. K., Huang, Y., James, A. E., Lam, L. W., and Chen, Z. Y. “Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet.” J. Nutr. 132, 5-10. 2002.
[4]	Shanthi, S., Parasakthy, K., Deepalakshmi, P. D., and Deveraj, S. N. “Hypolipidemic activity of tincture of Crataegus in rats.” Ind. J. Biochem. Biophys. 31, 143-146. 1994.
[5]	Schussler, M., Holzl, J., and Fricke U. “Myocardial effects of flavonoids from crataegus species.” Arzneim-Forch. 45, 842-845. 1995.
[6]	Hanack, T., and Bruckel, M. H. “The treatment of mild stable forms of angina pectoris using Crataegutt novo.” Ther. 33, 4331-4333. 1983.
[7]	von Eiff, M. “Hawthorn/passionflower extract and improvement in physical capacity of patients with dyspnoea Class II of the NYHM functional classification.” Acta Therap. 20, 47-66. 1983.
[8]	Vibes, J., Lasserre, B., Gleye, J., and Declume, C. “Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (hawthorn) flower heads.” Prostoglandiins Leukot Essent Fatty Acid. 50, 173-175. 1994.
[9]	Panetta, C., Jonk, Y., and Shapiro, A. “Prospective randomized clinical trial evaluating the impact of vinegar on lipids in non-diabetics.” World J. Cardiovas. Dis. 3, 191-196. 2013.
[10]	Johnston, C. S., Quagliano, S., and White, S. “Therapeutic effect of daily vinegar ingestion for individuals at risk for type 2 diabetes” (http://bragg.com/products).
[11]	Lee, J., Durst, R. W., and Wrolstad, R. E. “Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants and wines by the pH differential method: collaborative study.” J. AOAC Int. 88(5), 1269-1278. 2005.
[12]	Moon, J. H., and Terao, J. “Antioxidant activity of caffeic acid and dihydrocaffeic acid in lard and human low-density lipoprotein.” J. Agric. Food Chem. 46, 5062-5065. 1998.
[13]	Spanos, G. A., and Wrolstad, R. E. “Influence of processing and storage on the phenolic composition of Thompson seedless grape juice.” J. Agric. Food Chem. 38, 1565-1571. 1990.
[14]	Budak, N. H., Kumbul Doguc, D., Savas, C. M., Seydim, A. C., and Kok Tas, T. “Effects of apple cider vinegars produced with different techniques on blood lipids in high-cholesterol-fed rats.” J. Agric and Food Chem. 59, 6638-6644. 2011.
[15]	Cook, N. C., and Samman, S. “Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources.” Nutr. Biochem. 7, 66-76. 1996.
[16]	Johnston, C. S., White, A. M., and Kent, S. M. “Preliminary evidence that regular vinegar ingestion favorably influences hemoglobin A1c values in individuals with type 2 diabetes mellitus.” Diab. Res. Clin. Prac. 84(2), 15-17. 2009.
[17]	Nieto, S., Garrido, A., Sanhueza, J., Loyola, L., Morales, G., Leighton, F., and Valenzuela, A. “Flavonoids as stabilizers of fish oil: An alternative to synthetic antioxidants.” J. Am. Oil Chem. Soc. 70, 773-778. 1993.
[18]	Das, N. P., and Pereira, T. A. “Effects of flavonoids on thermal autoxidation of palm oil: Structure-activity relationship.” J. Agric. Food Chem. 44, 497-501. 1990.
[19]	Foti, M., Piattelli, M., Baratta, M. T., and Ruberto, G. “Flavonoids, coumarins and cinnamic acids as antioxidants in a micellar system. Structure-activity relationship.” J. Agric. Food Chem. 44, 497-501. 1996.
[20]	Huang, M.-T., Ho, C.-T., and Lee, C. Y. “Phenolic compounds in food and their effects on health.” II. Antioxidants and Cancer Prevention; ACS Symposium Series 507; American Chemical Society: Washington DC. 1992.
[21]	Velioglu, Y. S., Mazza, G., Gao, L., and Oomah, B. D. “Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products.” J. Agric. Food Chem. 46, 4113-4117. 1998.
[22]	Özcan, M., Hacıseferoğulları, H., Marakoğlu, T., and Arslan, D. “Hawthorn (Crataegus spp.) fruit: Some physical and chemical properties.” J. Food Eng. 69(4), 409-413. 2005.
[23]	Zhang, Z., Chang, Q., Zhu, M., Huang, Y., Ho, W. K. K., and Chen, Z.-Y. “Characterization of antioxidants present in hawthorn fruits.” J. Nutr.Biochem. 12(3), 144-152. 2001.
[24]	Brighenti, F., Castellani, G., Benini, L., Casiraghi, M. C., Leopardi, E., Crovetti, R., and Testolin, G. “Effect of neutralized and native vinegar on blood glucose and acetate response to a mixed meal in healthy subjects.” Eur. J. Clin. Nutr. 49, 242-247. 1995.
[25]	Liu, S., Willet, W. C., Stampfer, M. J., Hu, F. B., Franz, M., Sampson, L., Hennekens, C. H., and Manson, J. E. “A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women.” Am. J. Clin. Nutr. 71, 1455-1461. 2000.
[26]	Shahidi, F., McDonald, J., Chandrasekara, A., and Zhong, Y. “Phytochemicals of foods, beverages and fruit vinegars: Chemistry and health effects.” As. Pac. J. Clin. Nutr. 17(Suppl 1), 380-382. 2008.
[27]	Johnston, C. S., and Gaas, C. A. “Vinegar: Medicinal uses and antiglycemic effect.” Medspace General Med. 8, 61. 2006.
[28]	Fushimi, T., Suruga, K., and Oshima, Y. “Dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet.” British J. Nutr. 95, 916-924. 2006.
[29]	Kondo, S., Tayama, K., and Tsukamoto, Y. “Antihypertensive effects of acetic acid and vinegar on spontaneously hypertensive rats.” Biosci. Biotechnol. Biochem. 65, 2690-2694. 2001.
[30]	Kishi, M., Fukaya, M., and Tsukamoto, Y. “Enhancing effect of dietary vinegar on the intestinal absorption of calcium in ovariectomized rats.” Biosci. Biotechnol. Biochem. 63, 905-910. 1999.
[31]	Fushimi, T., Tayama, K., and Fukaya, M. “Acetic acid feeding enhances glycogen repletion in liver and skeletal muscle of rats.” J. Nutr. 131, 1973-1977. 2001.
[32]	Tauchert, M. ” Efficacy and safety of Crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure.” Am. Heart J. 143, 910-915. 2002.
[33]	Quettier-Deleu, C., Voiselle, G., Fruchart, J. C., Duriez, P., Teissier, E., Bailleul, F., Vasseur, J., and Trotin, F. “Hawthorn extracts inhibit LDL oxidation.” Pharmaz. 58, 577-581. 2003.
[34]	Pittler, M. H., Schmidt, K., and Ernst, E. “Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.” Am. J. Med. 114, 665-674. 2000.
[35]	Chang, W., Dao, J., and Shao, Z. “Hawthorn: Potential roles in cardiovascular disease.” Am. J. Clin. Med. 33, 1-10. 2005.
[36]	Kim, S. H., Kang, K. W., Kim, K. W., and Kim, N. D. “Procyanidins in Crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta.” Life Sci. 67, 121-131. 2000.